Neuroscience nanotechnology: progress, opportunities and challenges

Nanotechnologies exploit materials and devices with a functional organization that has been engineered at the nanometre scale. The application of nanotechnology in cell biology and physiology enables targeted interactions at a fundamental molecular level. In neuroscience, this entails specific interactions with neurons and glial cells. Examples of current research include technologies that are designed to better interact with neural cells, advanced molecular imaging technologies, materials and hybrid molecules used in neural regeneration, neuroprotection, and targeted delivery of drugs and small molecules across the blood–brain barrier.

[1]  H. Kleinman,et al.  Neural cell response to multiple novel sites on laminin‐1 , 2000, Journal of neuroscience research.

[2]  S. Mukherjee,et al.  Free radical pathology and antioxidant defense in schizophrenia: a review , 1996, Schizophrenia Research.

[3]  M. Mcshane,et al.  Micropatterning of nanoengineered surfaces to study neuronal cell attachment in vitro. , 2004, Biomacromolecules.

[4]  J. Engel,et al.  Domain structure and organisation in extracellular matrix proteins. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[5]  K. Roth,et al.  Combined Tyramide Signal Amplification and Quantum Dots for Sensitive and Photostable Immunofluorescence Detection , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  Tejal A Desai,et al.  Peptide-conjugated quantum dots activate neuronal receptors and initiate downstream signaling of neurite growth. , 2005, Nano letters.

[7]  J. Matthew Mauro,et al.  Long-term multiple color imaging of live cells using quantum dot bioconjugates , 2003, Nature Biotechnology.

[8]  J. Barker,et al.  CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels , 2004, Experimental Neurology.

[9]  H. Kleinman,et al.  Structure‐activity study of a laminin α1 chain active peptide segment Ile‐Lys‐Val‐Ala‐Val (IKVAV) , 1995 .

[10]  F. Cui,et al.  Culture of neural cells on silicon wafers with nano-scale surface topograph , 2002, Journal of Neuroscience Methods.

[11]  Alexander V Kabanov,et al.  Nanogels for oligonucleotide delivery to the brain. , 2004, Bioconjugate chemistry.

[12]  Peter Ramge,et al.  Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier , 2002, Journal of drug targeting.

[13]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[14]  S. Nie,et al.  Molecular profiling of single cells and tissue specimens with quantum dots. , 2003, Trends in biotechnology.

[15]  M. Delivoria-Papadopoulos,et al.  Cellular mechanisms of hypoxic injury in the developing brain , 1999, Brain Research Bulletin.

[16]  D D Allen,et al.  Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier , 2002, Drug development and industrial pharmacy.

[17]  R. Burgeson,et al.  Self-assembly of Laminin Isoforms* , 1997, The Journal of Biological Chemistry.

[18]  H. Kleinman,et al.  A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. , 1989, The Journal of biological chemistry.

[19]  R. Müller,et al.  Lipid-Drug-Conjugate (LDC) Nanoparticles as Novel Carrier System for the Hydrophilic Antitrypanosomal Drug Diminazenediaceturate , 2002, Journal of drug targeting.

[20]  H. Hansma,et al.  Atomic force microscopy imaging and pulling of nucleic acids. , 2004, Current opinion in structural biology.

[21]  Lars Montelius,et al.  In vitro sliding of actin filaments labelled with single quantum dots. , 2004, Biochemical and biophysical research communications.

[22]  Hedi Mattoussi,et al.  Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy , 2004, Nature Medicine.

[23]  J. Kreuter,et al.  Nanoparticulate systems for brain delivery of drugs. , 2001, Advanced drug delivery reviews.

[24]  Philippe Rostaing,et al.  Diffusion Dynamics of Glycine Receptors Revealed by Single-Quantum Dot Tracking , 2003, Science.

[25]  Lawrence T Scott,et al.  Methods for the chemical synthesis of fullerenes. , 2004, Angewandte Chemie.

[26]  Gabriel A Silva,et al.  Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system. , 2005, Surgical neurology.

[27]  Bruce C. Wheeler,et al.  Long-term maintenance of patterns of hippocampal pyramidal cells on substrates of polyethylene glycol and microstamped polylysine , 2000, IEEE Transactions on Biomedical Engineering.

[28]  Samuel I Stupp,et al.  Peptide-amphiphile nanofibers: A versatile scaffold for the preparation of self-assembling materials , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Choi,et al.  Buckminsterfullerenol Free Radical Scavengers Reduce Excitotoxic and Apoptotic Death of Cultured Cortical Neurons , 1996, Neurobiology of Disease.

[30]  R V Bellamkonda,et al.  The influence of physical structure and charge on neurite extension in a 3D hydrogel scaffold. , 1998, Journal of biomaterials science. Polymer edition.

[31]  B. Sabel,et al.  Nanoparticle technology for delivery of drugs across the blood-brain barrier. , 1998, Journal of pharmaceutical sciences.

[32]  Larry J Kricka,et al.  Nanobiotechnology: the promise and reality of new approaches to molecular recognition. , 2005, Trends in biotechnology.

[33]  B. Orr,et al.  A novel MEA/AFM platform for measurement of real-time, nanometric morphological alterations of electrically stimulated neuroblastoma cells , 2004, IEEE Transactions on NanoBioscience.

[34]  Karen A. Moxon,et al.  Nanostructured surface modification of ceramic-based microelectrodes to enhance biocompatibility for a direct brain-machine interface , 2004, IEEE Transactions on Biomedical Engineering.

[35]  J. Schlager,et al.  In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  Erkki Ruoslahti,et al.  Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Shen,et al.  Carboxyfullerenes as neuroprotective agents. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Silva.  Small Neuroscience: The Nanostructure of the Central Nervous System and Emerging Nanotechnology Applications , 2005 .

[39]  R. Mumper,et al.  In Situ Blood–Brain Barrier Transport of Nanoparticles , 2003, Pharmaceutical Research.

[40]  K. Jacobson,et al.  Single-particle tracking: applications to membrane dynamics. , 1997, Annual review of biophysics and biomolecular structure.

[41]  S. Ramakrishna,et al.  Fabrication of nano-structured porous PLLA scaffold intended for nerve tissue engineering. , 2004, Biomaterials.

[42]  Izumi Ichinose,et al.  Biocompatibility of layer-by-layer self-assembled nanofilm on silicone rubber for neurons , 2003, Journal of Neuroscience Methods.

[43]  G J Brewer,et al.  Microcontact printing for precise control of nerve cell growth in culture. , 1999, Journal of biomechanical engineering.

[44]  K. O’Malley,et al.  Fullerene-based antioxidants and neurodegenerative disorders. , 2001, Parkinsonism & related disorders.

[45]  H. Mattoussi,et al.  Use of quantum dots for live cell imaging , 2004, Nature Methods.

[46]  G J Brewer,et al.  Modulation of neural network activity by patterning. , 2001, Biosensors & bioelectronics.

[47]  M. Bruchez,et al.  Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots , 2003, Nature Biotechnology.

[48]  T. Hirano,et al.  Quantum dots in bio-imaging: Revolution by the small. , 2005, Biochemical and biophysical research communications.

[49]  Helene Andersson,et al.  Microfabrication and microfluidics for tissue engineering: state of the art and future opportunities. , 2004, Lab on a chip.

[50]  R. Löbenberg,et al.  Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro , 2001, Journal of drug targeting.

[51]  Robert F Standaert,et al.  Activation of membrane receptors by a neurotransmitter conjugate designed for surface attachment. , 2005, Biomaterials.

[52]  F Tokumasu,et al.  Development and application of quantum dots for immunocytochemistry of human erythrocytes , 2003, Journal of microscopy.

[53]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.

[54]  Michael C. Wilson,et al.  Surfactant-assisted synthesis of water-soluble and biocompatible semiconductor quantum dot micelles. , 2005, Nano letters.

[55]  M. Shoichet,et al.  Guided cell adhesion and outgrowth in peptide-modified channels for neural tissue engineering. , 2005, Biomaterials.

[56]  D. Begley,et al.  Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles , 2003, Pharmaceutical Research.

[57]  Eng H. Lo,et al.  Neurological diseases: Mechanisms, challenges and opportunities in stroke , 2003, Nature Reviews Neuroscience.

[58]  T. Park,et al.  Integration of Cell Culture and Microfabrication Technology , 2003, Biotechnology progress.

[59]  Laurent D. Cohen,et al.  A multiple target approach for single quantum dot tracking , 2004, 2004 2nd IEEE International Symposium on Biomedical Imaging: Nano to Macro (IEEE Cat No. 04EX821).

[60]  J. Blass.  Cerebrometabolic abnormalities in Alzheimer's disease , 2003, Neurological research.

[61]  David A Feldheim,et al.  Preparation of protein gradients through the controlled deposition of protein-nanoparticle conjugates onto functionalized surfaces. , 2004, Journal of the American Chemical Society.

[62]  C. Lieber,et al.  Nanowire Nanosensors for Highly Sensitive and Selective Detection of Biological and Chemical Species , 2001, Science.

[63]  Yang D. Teng,et al.  The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue , 2002, Nature Biotechnology.

[64]  Hassan S. Bazzi,et al.  Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots , 2005, Journal of Molecular Medicine.

[65]  Naomi J Halas,et al.  Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics. , 2003, Annual review of biomedical engineering.

[66]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[67]  Charles Tator,et al.  Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection. , 2006, Biomaterials.

[68]  R. Gagliardi.  Neuroprotection, excitotoxicity and NMDA antagonists. , 2000, Arquivos de neuro-psiquiatria.

[69]  M. Shoichet,et al.  Macroporous interconnected dextran scaffolds of controlled porosity for tissue-engineering applications. , 2005, Biomaterials.

[70]  R V Bellamkonda,et al.  Agarose gel stiffness determines rate of DRG neurite extension in 3D cultures. , 2001, Biomaterials.

[71]  Felix Stang,et al.  Collagen nerve conduits--assessment of biocompatibility and axonal regeneration. , 2005, Bio-medical materials and engineering.

[72]  S. Nie,et al.  Luminescent quantum dots for multiplexed biological detection and imaging. , 2002, Current opinion in biotechnology.

[73]  José L. Segura,et al.  New Concepts in Tetrathiafulvalene Chemistry. , 2001, Angewandte Chemie.

[74]  F. Zanella,et al.  Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma. , 2002, Toxicology letters.

[75]  T. Moore,et al.  Photochemistry of supramolecular systems containing C60. , 2000, Journal of photochemistry and photobiology. B, Biology.

[76]  P. Couvreur,et al.  A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles , 2005, Cellular and Molecular Life Sciences.

[77]  M. Bruchez,et al.  Lighting up cells with quantum dots. , 2003, BioTechniques.

[78]  T. Iwaki,et al.  Photofabricated Gelatin-Based Nerve Conduits: Nerve Tissue Regeneration Potentials , 2004, Cell transplantation.

[79]  Jim Giles,et al.  Nanotechnology: What is there to fear from something so small? , 2003, Nature.

[80]  Conrad D. James,et al.  Patterning Axonal Guidance Molecules Using a Novel Strategy for Microcontact Printing , 2003, Neurochemical Research.

[81]  Laurent D. Cohen,et al.  Single quantum dot tracking based on perceptual Grouping using minimal paths in a spatiotemporal volume , 2005, IEEE Transactions on Image Processing.

[82]  Sungho Jin,et al.  Quantum Dot Applications to Neuroscience: New Tools for Probing Neurons and Glia , 2006, The Journal of Neuroscience.

[83]  Rivelino Montenegro,et al.  Coil-reinforced hydrogel tubes promote nerve regeneration equivalent to that of nerve autografts. , 2006, Biomaterials.

[84]  Krista L. Niece,et al.  Selective Differentiation of Neural Progenitor Cells by High-Epitope Density Nanofibers , 2004, Science.

[85]  G. Vassal,et al.  Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting , 2002, Journal of Pharmacology and Experimental Therapeutics.

[86]  David C. Martin,et al.  Conducting polymers grown in hydrogel scaffolds coated on neural prosthetic devices. , 2004, Journal of biomedical materials research. Part A.

[87]  S. Stupp,et al.  Self-Assembly and Mineralization of Peptide-Amphiphile Nanofibers , 2001, Science.

[88]  Miguel A R B Castanho,et al.  An overview of the biophysical applications of atomic force microscopy. , 2003, Biophysical chemistry.

[89]  J. Reif,et al.  DNA nanotubes self-assembled from triple-crossover tiles as templates for conductive nanowires. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[90]  T. Desai,et al.  Assembly and characterization of biofunctional neurotransmitter-immobilized surfaces for interaction with postsynaptic membrane receptors. , 2003, Journal of biomedical materials research. Part A.

[91]  Jing Zhang,et al.  Chiral nanotechnology. , 2005, Chirality.

[92]  C. Murphy.  Optical sensing with quantum dots. , 2002, Analytical chemistry.

[93]  Raymond P. Molloy,et al.  In vivo multiphoton microscopy of deep brain tissue. , 2004, Journal of neurophysiology.

[94]  M. Howarth,et al.  Targeting quantum dots to surface proteins in living cells with biotin ligase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[95]  J. Giles.  Size matters when it comes to safety, report warns , 2004, Nature.

[96]  J. Wu,et al.  Polyhydroxylated C60, fullerenols, as glutamate receptor antagonists and neuroprotective agents , 2000, Journal of neuroscience research.

[97]  M. Paulsson,et al.  Laminins: Structure and genetic regulation , 2000, Microscopy research and technique.

[98]  J. Post,et al.  Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transduction , 2004, Nature Biotechnology.